Acuta Capital Partners’s Arcus Biosciences RCUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-167,500	Closed	-$4.24M	–	53
2022 Q2	$4.24M	Buy	+167,500	New	+$4.24M	2.36%	14